Livak Method Calculators
0 calculators tagged with “Livak Method”
All Calculators
No calculators found for this topic.
What Is the Livak Method?
The Livak method calculates the relative expression of a target gene in a treated/experimental sample compared to an untreated/control sample, normalized to a reference gene to control for differences in RNA input and cDNA synthesis efficiency. The formula is:
Fold change = 2^(−ΔΔCt)
Where:
- ΔCt (sample) = Ct(target gene) − Ct(reference gene) for the experimental sample
- ΔCt (control) = Ct(target gene) − Ct(reference gene) for the control sample
- ΔΔCt = ΔCt(experimental) − ΔCt(control)
Step-by-Step Calculation
Example: You want to know if Drug X increases expression of Gene A.
- Measure Ct for Gene A in treated cells: Ct = 22.0
- Measure Ct for GAPDH (reference gene) in treated cells: Ct = 18.0
- ΔCt (treated) = 22.0 − 18.0 = 4.0
- Measure Ct for Gene A in control cells: Ct = 25.0
- Measure Ct for GAPDH in control cells: Ct = 18.5
- ΔCt (control) = 25.0 − 18.5 = 6.5
- ΔΔCt = 4.0 − 6.5 = −2.5
- Fold change = 2^(−(−2.5)) = 2^2.5 = 5.66-fold increase
Key Assumptions
The Livak method assumes:
- ~100% PCR efficiency for both target and reference genes (the basis of the 2 in the formula — each cycle doubles the amplicon)
- Equal efficiency between target and reference gene amplifications
- The reference gene is stable (not differentially expressed between conditions)
If PCR efficiency is not ~100% or differs between assays, the Pfaffl method (which incorporates efficiency values) gives more accurate results.
Choosing a Reference Gene
Reference gene selection is critical. Commonly used housekeeping genes (GAPDH, β-actin, 18S rRNA, HPRT1, RPL13A) may not be stable under all experimental conditions. Best practice:
- Test at least 2–3 candidate reference genes
- Use stability analysis software (geNorm, NormFinder, RefFinder) to identify the most stable gene(s)
- When possible, normalize to the geometric mean of 2–3 stable reference genes
Glossary
Frequently Asked Questions
The 2^−ΔΔCt formula calculates the fold change in target gene expression between an experimental and control sample, normalized to a reference gene. A result of 2.0 means the target gene is expressed 2-fold higher in the experimental condition; 0.5 means 2-fold lower. The formula assumes ~100% PCR amplification efficiency (doubling per cycle, hence the base of 2).
ΔCt (delta Ct) is the difference between the Ct of the target gene and the reference gene within a single sample: ΔCt = Ct(target) − Ct(reference). It normalizes target expression to the reference. ΔΔCt (delta delta Ct) is the difference between two ΔCt values — the experimental minus the control: ΔΔCt = ΔCt(experimental) − ΔCt(control). It compares normalized expression between conditions.
If PCR efficiency deviates significantly from 100%, the 2^−ΔΔCt calculation will give inaccurate fold changes. A 90% efficiency means the true base should be 1.9, not 2.0. When efficiencies differ between target and reference genes, errors compound. The Pfaffl method corrects for this by measuring the actual efficiency of each assay and incorporating it into the calculation: Ratio = (E_target^ΔCt_target) / (E_ref^ΔCt_ref).
No single reference gene is universally stable. Common choices include GAPDH, β-actin, HPRT1, RPL13A, and 18S rRNA — but all can be regulated under certain conditions (e.g., GAPDH is affected by hypoxia; β-actin by cytoskeletal changes). Best practice is to test 3–5 candidate genes and use stability analysis tools (geNorm, NormFinder) to identify the most stably expressed genes in your specific experimental context, then normalize to the geometric mean of 2–3 stable genes.